Moderately hypofractionated radiotherapy for localized prostate cancer: updated long-term outcome and toxicity analysis

被引：0
|
作者：
Jörg Tamihardja
Max Schortmann
Ingulf Lawrenz
Stefan Weick
Klaus Bratengeier
Michael Flentje
Matthias Guckenberger
Bülent Polat
机构：
[1] University Hospital Wuerzburg,Department of Radiation Oncology
[2] University of Wuerzburg,Department of Radiation Oncology
[3] University Hospital Zurich,undefined
[4] University of Zurich,undefined
来源：
Strahlentherapie und Onkologie | 2021年 / 197卷
关键词：
Simultaneous integrated boost; Cone beam CT; Hypofractionation; Intensity-modulated radiation therapy; Image-guided radiation therapy;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：124 / 132
页数：8
相关论文
共 50 条
  • [41] Hypofractionated conformal radiotherapy in carcinoma of the prostate: Five-year outcome analysis
    Livsey, JE
    Cowan, RA
    Wylie, JP
    Swindell, R
    Read, G
    Khoo, VS
    Logue, JP
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2003, 57 (05): : 1254 - 1259
  • [42] Acute Toxicity After CyberKnife-Delivered Hypofractionated Radiotherapy for Treatment of Prostate Cancer
    Townsend, Natasa C.
    Huth, Bradley J.
    Ding, William
    Garber, Bruce
    Mooreville, Michael
    Arrigo, Stephen
    Lamond, John
    Brady, Luther W.
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2011, 34 (01): : 6 - 10
  • [43] Post-operative hypofractionated radiotherapy for prostate cancer: a mono-institutional analysis of toxicity and clinical outcomes
    Giuseppe Ferrera
    Salvatore D’Alessandro
    Francesco Cuccia
    Vincenzo Serretta
    Giovanna Trapani
    Gianfranco Savoca
    Gianluca Mortellaro
    Antonio Lo Casto
    Journal of Cancer Research and Clinical Oncology, 2022, 148 : 89 - 95
  • [44] Post-operative hypofractionated radiotherapy for prostate cancer: a mono-institutional analysis of toxicity and clinical outcomes
    Ferrera, Giuseppe
    D'Alessandro, Salvatore
    Cuccia, Francesco
    Serretta, Vincenzo
    Trapani, Giovanna
    Savoca, Gianfranco
    Mortellaro, Gianluca
    Lo Casto, Antonio
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2022, 148 (01) : 89 - 95
  • [45] Late results of a randomized trial on the role of mild hypofractionated radiotherapy for the treatment of localized prostate cancer
    Alexidis, Petros
    Karatzoglou, Sotirios
    Dragoumis, Dimitris
    Drevelegas, Konstantinos
    Tzitzikas, Ioannis
    Hatzimouratidis, Konstantinos
    Chrisogonidis, Ioannis
    Ioannidis, Aris
    Katsios, Iason Nikolaos
    Zarogoulidis, Paul
    Sapalidis, Konstantinos
    Koulouris, Charilaos
    Michalopoulos, Nikolaos
    Giannakidis, Dimitrios
    Aidoni, Zoi
    Fyntanidou, Varbara
    Amaniti, Aikaterini
    Boniou, Konstantina
    Kesisoglou, Isaak
    Vagionas, Anastasios
    Romanidis, Konstantinos
    Oikonomou, Panagoula
    Goganau, Alexandru Marian
    Petanidis, Savas
    Maragouli, Elena
    Kosmidis, Christoforos
    JOURNAL OF CANCER, 2020, 11 (05): : 1008 - 1016
  • [46] Long-term oncologic outcomes of low dose-rate brachytherapy compared to hypofractionated external beam radiotherapy for intermediate -risk prostate cancer
    Sanmamed, Noelia
    Joseph, Lisa
    Crook, Juanita
    Craig, Tim
    Warde, Padraig
    Di Tomasso, Anne
    Chung, Peter
    Berlin, Alejandro
    Bayley, Andrew
    Saibishkumar, Elantholi P.
    Glicksman, Rachel
    Raman, Srinivas
    Catton, Charles
    Helou, Joelle
    BRACHYTHERAPY, 2023, 22 (02) : 188 - 194
  • [47] Hypofractionated Radiotherapy in Localized, Low-Intermediate-Risk Prostate Cancer: Current and Future Prospectives
    Lo Greco, Maria Chiara
    Marletta, Giulia
    Marano, Giorgia
    Fazio, Alessandro
    Buffettino, Emanuele
    Iudica, Arianna
    Liardo, Rocco Luca Emanuele
    Milazzotto, Roberto
    Foti, Pietro Valerio
    Palmucci, Stefano
    Basile, Antonio
    Marletta, Francesco
    Cuccia, Francesco
    Ferrera, Giuseppe
    Parisi, Silvana
    Pontoriero, Antonio
    Pergolizzi, Stefano
    Spatola, Corrado
    MEDICINA-LITHUANIA, 2023, 59 (06):
  • [48] The role of hypofractionated radiotherapy for the definitive treatment of localized prostate cancer: early results of a randomized trial
    Alexidis, Petros
    Dragoumis, Dimitris
    Karatzoglou, Sotirios
    Drevelegas, Konstantinos
    Tzitzikas, Ioannis
    Hatzimouratidis, Konstantinos
    Chrisogonidis, Ioannis
    Giannakidis, Dimitris
    Koulouris, Charilaos
    Katsaounis, Athanasios
    Michalopoulos, Nikolaos
    Huang, Haidong
    Li, Qiang
    Aidoini, Zoi
    Fyntanidou, Varbara
    Amaniti, Aikaterini
    Hohenforst-Schmidt, Wolfgang
    Maragouli, Elena
    Petanidis, Savvas
    Zarogoulidis, Paul
    Sapalidis, Konstantinos
    Kosmidis, Christoforos
    Romanidis, Konstantinos
    Oinkonomou, Panagoula
    Vagionas, Anastasios
    Nikolaos-Katsios, Iason
    Ioannidis, Aris
    Boniou, Konstantina
    Kesisoglou, Isaak
    JOURNAL OF CANCER, 2019, 10 (25): : 6217 - 6224
  • [49] Long-term results of hypofractionated radiotherapy and hormonal therapy without surgery for breast cancer in elderly patients
    Courdi, Adel
    Ortholan, Cecile
    Hannoun-Levi, Jean-Michel
    Ferrero, Jean-Marc
    Largillier, Remy
    Balu-Maestro, Catherine
    Chapellier, Claire
    Ettore, Francette
    Birtwisle-Peyrottes, Isabelle
    RADIOTHERAPY AND ONCOLOGY, 2006, 79 (02) : 156 - 161
  • [50] Hypofractionated accelerated radiotherapy using concomitant intensity-modulated radiotherapy boost technique for localized high-risk prostate cancer: Acute toxicity result
    Lim, Tee S.
    Cheung, Patrick C. F.
    Loblaw, D. Andrew
    Morton, Gerard
    Sixel, Katharina E.
    Pang, Geordi
    Basran, Parminder
    Zhang, Liying
    Tirona, Romeo
    Szumacher, Ewa
    Danjoux, Cyril
    Choo, Richard
    Thomas, Gillian
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2008, 72 (01): : 85 - 92
12345